Prevalence and management of dyslipidemia in Korea: Korea national health and nutrition examination survey during 1998 to 2010

Eun Roh, Seung Hyun Ko, Hyuk Sang Kwon, Nan Hee Kim, Jae Hyeon Kim, Chul Sik Kim, Kee Ho Song, Jong Chul Won, Dae Jung Kim, Sung Hee Choi, Soo Lim, Bong Yun Cha

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (<40 mg/dL in men and <50 mg/dL in women). Results: The number of participants was 6,921, 4,894, 5,312, 2,733, 6,295, 6,900, and 5,738 in KNHANES 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Age-standardized prevalence rates of dyslipidemia were 54.0%, 65.8%, 66.5%, 60.6%, 58.7%, 58.9%, and 59.0% in 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Hypertriglyceridemia and hypo-HDL-cholesterolemia were the two most frequent lipid abnormalities. The overall prevalence of hypercholesterolemia and hyper-LDL-cholesterolemia increased by 1.36- and 1.35-fold in 2010 compared with 2007, respectively. Awareness, treatment, and control rates of dyslipidemia improved over the period of surveys in both sexes. In 2010, about 30% of dyslipidemic patients who received lipid-lowering treatment reached target levels. Conclusion: Although the management status of dyslipidemia has improved during recent years, effective strategy is required for achieving better prevention, treatment, and control of dyslipidemia.

Original languageEnglish
Pages (from-to)433-449
Number of pages17
JournalDiabetes and Metabolism Journal
Volume37
Issue number6
DOIs
Publication statusPublished - 2013 Dec 1

Fingerprint

Nutrition Surveys
Korea
Dyslipidemias
Lipids
Hypertriglyceridemia
HDL Lipoproteins
Hypercholesterolemia
Health Surveys
LDL Lipoproteins
Cholesterol
Therapeutics
Pharmaceutical Preparations
Cardiovascular Diseases
Education

Keywords

  • Dyslipidemia, Korea
  • Prevalence

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Prevalence and management of dyslipidemia in Korea : Korea national health and nutrition examination survey during 1998 to 2010. / Roh, Eun; Ko, Seung Hyun; Kwon, Hyuk Sang; Kim, Nan Hee; Kim, Jae Hyeon; Kim, Chul Sik; Song, Kee Ho; Won, Jong Chul; Kim, Dae Jung; Choi, Sung Hee; Lim, Soo; Cha, Bong Yun.

In: Diabetes and Metabolism Journal, Vol. 37, No. 6, 01.12.2013, p. 433-449.

Research output: Contribution to journalArticle

Roh, E, Ko, SH, Kwon, HS, Kim, NH, Kim, JH, Kim, CS, Song, KH, Won, JC, Kim, DJ, Choi, SH, Lim, S & Cha, BY 2013, 'Prevalence and management of dyslipidemia in Korea: Korea national health and nutrition examination survey during 1998 to 2010', Diabetes and Metabolism Journal, vol. 37, no. 6, pp. 433-449. https://doi.org/10.4093/dmj.2013.37.6.433
Roh, Eun ; Ko, Seung Hyun ; Kwon, Hyuk Sang ; Kim, Nan Hee ; Kim, Jae Hyeon ; Kim, Chul Sik ; Song, Kee Ho ; Won, Jong Chul ; Kim, Dae Jung ; Choi, Sung Hee ; Lim, Soo ; Cha, Bong Yun. / Prevalence and management of dyslipidemia in Korea : Korea national health and nutrition examination survey during 1998 to 2010. In: Diabetes and Metabolism Journal. 2013 ; Vol. 37, No. 6. pp. 433-449.
@article{aee698e36f8648c68e59e8e5ff43af54,
title = "Prevalence and management of dyslipidemia in Korea: Korea national health and nutrition examination survey during 1998 to 2010",
abstract = "Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (<40 mg/dL in men and <50 mg/dL in women). Results: The number of participants was 6,921, 4,894, 5,312, 2,733, 6,295, 6,900, and 5,738 in KNHANES 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Age-standardized prevalence rates of dyslipidemia were 54.0{\%}, 65.8{\%}, 66.5{\%}, 60.6{\%}, 58.7{\%}, 58.9{\%}, and 59.0{\%} in 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Hypertriglyceridemia and hypo-HDL-cholesterolemia were the two most frequent lipid abnormalities. The overall prevalence of hypercholesterolemia and hyper-LDL-cholesterolemia increased by 1.36- and 1.35-fold in 2010 compared with 2007, respectively. Awareness, treatment, and control rates of dyslipidemia improved over the period of surveys in both sexes. In 2010, about 30{\%} of dyslipidemic patients who received lipid-lowering treatment reached target levels. Conclusion: Although the management status of dyslipidemia has improved during recent years, effective strategy is required for achieving better prevention, treatment, and control of dyslipidemia.",
keywords = "Dyslipidemia, Korea, Prevalence",
author = "Eun Roh and Ko, {Seung Hyun} and Kwon, {Hyuk Sang} and Kim, {Nan Hee} and Kim, {Jae Hyeon} and Kim, {Chul Sik} and Song, {Kee Ho} and Won, {Jong Chul} and Kim, {Dae Jung} and Choi, {Sung Hee} and Soo Lim and Cha, {Bong Yun}",
year = "2013",
month = "12",
day = "1",
doi = "10.4093/dmj.2013.37.6.433",
language = "English",
volume = "37",
pages = "433--449",
journal = "Diabetes and Metabolism Journal",
issn = "2233-6079",
publisher = "Korean Diabetes Association",
number = "6",

}

TY - JOUR

T1 - Prevalence and management of dyslipidemia in Korea

T2 - Korea national health and nutrition examination survey during 1998 to 2010

AU - Roh, Eun

AU - Ko, Seung Hyun

AU - Kwon, Hyuk Sang

AU - Kim, Nan Hee

AU - Kim, Jae Hyeon

AU - Kim, Chul Sik

AU - Song, Kee Ho

AU - Won, Jong Chul

AU - Kim, Dae Jung

AU - Choi, Sung Hee

AU - Lim, Soo

AU - Cha, Bong Yun

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (<40 mg/dL in men and <50 mg/dL in women). Results: The number of participants was 6,921, 4,894, 5,312, 2,733, 6,295, 6,900, and 5,738 in KNHANES 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Age-standardized prevalence rates of dyslipidemia were 54.0%, 65.8%, 66.5%, 60.6%, 58.7%, 58.9%, and 59.0% in 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Hypertriglyceridemia and hypo-HDL-cholesterolemia were the two most frequent lipid abnormalities. The overall prevalence of hypercholesterolemia and hyper-LDL-cholesterolemia increased by 1.36- and 1.35-fold in 2010 compared with 2007, respectively. Awareness, treatment, and control rates of dyslipidemia improved over the period of surveys in both sexes. In 2010, about 30% of dyslipidemic patients who received lipid-lowering treatment reached target levels. Conclusion: Although the management status of dyslipidemia has improved during recent years, effective strategy is required for achieving better prevention, treatment, and control of dyslipidemia.

AB - Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (<40 mg/dL in men and <50 mg/dL in women). Results: The number of participants was 6,921, 4,894, 5,312, 2,733, 6,295, 6,900, and 5,738 in KNHANES 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Age-standardized prevalence rates of dyslipidemia were 54.0%, 65.8%, 66.5%, 60.6%, 58.7%, 58.9%, and 59.0% in 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Hypertriglyceridemia and hypo-HDL-cholesterolemia were the two most frequent lipid abnormalities. The overall prevalence of hypercholesterolemia and hyper-LDL-cholesterolemia increased by 1.36- and 1.35-fold in 2010 compared with 2007, respectively. Awareness, treatment, and control rates of dyslipidemia improved over the period of surveys in both sexes. In 2010, about 30% of dyslipidemic patients who received lipid-lowering treatment reached target levels. Conclusion: Although the management status of dyslipidemia has improved during recent years, effective strategy is required for achieving better prevention, treatment, and control of dyslipidemia.

KW - Dyslipidemia, Korea

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84892147694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892147694&partnerID=8YFLogxK

U2 - 10.4093/dmj.2013.37.6.433

DO - 10.4093/dmj.2013.37.6.433

M3 - Article

AN - SCOPUS:84892147694

VL - 37

SP - 433

EP - 449

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

SN - 2233-6079

IS - 6

ER -